Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.3T | 2.4T | 2.1T | 1.8T |
Cost of revenue | 2.1T | 2.3T | 1.9T | 1.6T |
Gross profit | 156.7B | 146.2B | 141.0B | 152.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 7.6B | -16.9B | 15.8B | 15.4B |
Other operating expenses | 14.8B | 15.9B | 11.9B | 13.9B |
Operating income | 116.4B | 124.0B | 96.2B | 108.8B |
Non operating interest income | ||||
Income | 5.9B | 6.4B | 7.3B | 7.5B |
Expense | 0 | 289.3M | 2.5M | 0 |
Other income expense | — | — | — | — |
Pretax income | 125.0B | 135.7B | 95.2B | 118.1B |
Tax provision | 26.4B | 28.8B | 20.9B | 24.7B |
Net income | 98.6B | 106.9B | 74.3B | 93.5B |
Basic EPS | 166 | — | — | — |
Diluted EPS | 166 | — | — | — |
Basic average shares | 595M | — | — | — |
Diluted average shares | 595M | — | — | — |
EBITDA | 125.9B | 137.0B | 96.4B | 119.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |